Pall Corporation’s filtration technology plays critical role in EverGrain‘s new large-scale protein facility
Pall Corporation’s new Supralon Filter Element Advances Equipment Protection and Reduces Energy Costs
Pall Arabia, a Pall Corporation Joint Venture, Expands Manufacturing Capabilities to Include Advanced Liquid/Gas Separation Technology
June 1, 2021: Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform.
April 1, 2021: Major capacity expansion underway to support increase in industry demand
March 31, 2021: New acquisition will help support single-use technology demand driven by COVID-19
Kwasi Kwarteng, UK Secretary of State for Business, Energy and Industrial Strategy visits Pall’s Portsmouth, UK locations
January 7, 2021: Pall Corporation expands production capacity in the United States and Europe to support industry demand
Pall Corporation and Single Use Support Partner to Safeguard Storage and Transport Critical Biopharmaceuticals
Pall Corporation Awarded $4.9 Million Department of Defense Contract to Build Ventilator Filter Manufacturing Line
Pall joins a consortium led by Oxford University in fast-tracking clinical trials for a COVID-19 vaccine beginning April 2020.
Pall Corporation Announces Strategic Partnership with the Association for Professionals in Infection Control and Epidemiology
Pall Corporation Chosen as Single-Source Supplier by Servier for Purpose Built End-to-End Biomanufacturing Facility in Gidy, France
July 16, 2019: Servier chooses Pall as exclusive technology and services provider for planned Bio-S biomanufacturing facility in France
Freeline Announces the Implementation of the Pall Corporation iCELLis® Bioreactor System to Enable Commercial Scale, In-House Manufacturing of AAV Gene Therapies
April 29, 2019: Freeline's (AAV) manufacturing platform and Pall’s iCELLis bioreactor system combine to achieve commercial-scale and high quality production of AAV gene therapy vectors